Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East

BACKGROUND: Evidence on the use of fingolimod in real-world clinical practice and data on patient-reported health-related quality of life (HRQoL) in countries such as the Middle East are sparse. The Prospective Evaluation of Treatment with Fingolimod for Multiple Sclerosis (PERFORMS) study assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Achiron, Anat, Aref, Hany, Inshasi, Jihad, Harb, Mohamad, Alroughani, Raed, Bijarnia, Mahendra, Cooke, Kathryn, Yuksel, Ozgur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547540/
https://www.ncbi.nlm.nih.gov/pubmed/28784108
http://dx.doi.org/10.1186/s12883-017-0913-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547540/
https://www.ncbi.nlm.nih.gov/pubmed/28784108
http://dx.doi.org/10.1186/s12883-017-0913-3

Ejemplares similares